微创与开放腹胸联合食管切除术治疗食管癌的随机对照试验(MIVATE)研究方案
MIVATE是一项以专长为基础的优越性随机对照试验,比较全微创食管切除术(MIE)联合线性吻合器吻合与开放食管切除术(OE)联合圆形吻合器吻合的术后并发症情况。研究对象为18岁及以上、远端食管可切除原发恶性肿瘤患者,主要终点为术后30天内综合并发症指数(CCI)评估的术后并发症,每组样本量按20例计算。
要点
- MIVATE首次在胸腔内吻合中比较OE圆形吻合与全MIE线性吻合。
- 采用专长基础设计,各术式仅由该中心最有经验的外科医生实施以减少偏倚。
- 主要终点为术后30天内按CCI评估的术后并发症,每组计划20例。
核心结论
- MIVATE是首个仅针对胸腔内吻合、比较开放食管切除术联合圆形吻合器吻合与全微创食管切除术联合线性吻合器吻合的随机对照试验。
- 研究结果将用于确定哪种术式对需行食管切除术的患者具有最佳围手术期结局。
研究设计与样本
- 优越性随机对照试验,比较MIE联合线性吻合器吻合(干预组)与OE联合圆形吻合器吻合(对照组)的Ivor-Lewis食管切除术。
- 2019年2月启动,预计招募持续3年;采用专长基础方法,各术式仅由该中心最有经验的外科医生实施。
- 纳入标准为18岁及以上、远端食管可切除原发恶性肿瘤;排除肿瘤位于奇静脉以上、转移或侵犯邻近组织者。
- 主要终点术后30天内按综合并发症指数(CCI)评估的术后并发症,每组样本量按20例计算。
关键数值与推荐
- 主要终点为术后30天内根据综合并发症指数(CCI)评估的术后并发症。
- 次要终点包括吻合口功能不全、肺部并发症、估计失血量、手术时间、住院时间、短期肿瘤学终点、标准化快速康复方案依从性、术后疼痛及术后恢复(QoR-15)。
- 生活质量采用SF-36、CAT EORTC QLQ-C30、CAT EORTC QLQ-OES18评估,肿瘤学结局随访60个月。
- 试验注册于德国临床试验注册中心DRKS00016773,2019年2月18日注册。
临床怎么用
- 两种术式均采用专门快速康复方案,有助于阐明仅手术入路策略本身在该情境中的作用。
- 专长基础设计可减少因外科技术水平异质性导致的偏倚,为术式比较提供更可靠证据。
局限性
- 每组样本量按20例计算,样本量较小。
- 招募预计持续3年,研究尚在进行中,结果尚未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The only curative treatment for most esophageal cancers is radical esophagectomy. Minimally invasive esophagectomy (MIE) aims to reduce postoperative morbidity, but is not yet widely established. Linear stapled anastomosis is a promising technique for MIE because it is quite feasible even without robotic assistance. The aim of the present study is to compare total MIE with linear stapled anastomosis to open esophagectomy (OE) with circular stapled anastomosis with special regard to postoperative morbidity in an expertise-based randomized controlled trial (RCT). METHODS/DESIGN: This superiority RCT compares MIE with linear stapled anastomosis (intervention) to OE with circular stapled anastomosis (control) for Ivor-Lewis esophagectomy. It was initiated in February 2019, and recruitment is expected to last for 3 years. For inclusion, patients must be 18 years of age or more with a resectable primary malignancy in the distal esophagus. Participants with tumor localizations above the azygos vein, metastasis, or infiltration into adjacent tissue will be excluded. In an expertise-based approach, the allocated treatment will only be carried out by the single most experienced surgeon of the surgical center for each respective technique. The sample size was calculated with 20 participants per group for the primary endpoint postoperative morbidity according to comprehensive complication index (CCI) within 30 postoperative days. Secondary endpoints include anastomotic insufficiency, pulmonary complications, other intra- and postoperative outcome parameters such as estimated blood loss, operative time, length of stay, short-term oncologic endpoints, adherence to a standardized fast-track protocol, postoperative pain, and postoperative recovery (QoR-15). Quality of life (SF-36, CAT EORTC QLQ-C30, CAT EORTC QLQ-OES18) and oncological outcomes are evaluated with 60 months follow-up. DISCUSSION: MIVATE is the first RCT to compare OE with circular stapled anastomosis to total MIE with linear stapled anastomosis exclusively for intrathoracic anastomosis. The expertise-based approach limits bias due to heterogeneity of surgical expertise. The use of a dedicated fast-track protocol in both OE and MIE will shed light on the role of the access strategy alone in this setting. The findings of this study will serve to define which approach has the best perioperative outcome for patients requiring esophagectomy. TRIAL REGISTRATION: German Clinical Trials Register DRKS00016773 . Registered on 18 February 2019.
引用
- Nickel F, Probst P, Studier-Fischer A, et al. Minimally Invasive Versus open AbdominoThoracic Esophagectomy for esophageal carcinoma (MIVATE) - study protocol for a randomized controlled trial DRKS00016773. Trials. 2021. PMID: 33430937. doi:10.1186/s13063-020-04966-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。